Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects

Jussi Mattila (Corresponding Author), Hilkka Soininen, Juha Koikkalainen, Daniel Rueckert, Robin Wolz, Gunhild Waldemar, Jyrki Lötjönen

Research output: Contribution to journalArticleScientificpeer-review

23 Citations (Scopus)

Abstract

In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60–80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6–54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.
Original languageEnglish
Pages (from-to)969-979
JournalJournal of Alzheimer's Disease
Volume32
Issue number4
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fingerprint

Alzheimer Disease
Ambulatory Care
Cognitive Dysfunction
Confidence Intervals

Keywords

  • Clinical decision support
  • early Alzheimer's disease
  • mild cognitive impairment
  • patient selection

Cite this

Mattila, J., Soininen, H., Koikkalainen, J., Rueckert, D., Wolz, R., Waldemar, G., & Lötjönen, J. (2012). Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. Journal of Alzheimer's Disease, 32(4), 969-979. https://doi.org/10.3233/JAD-2012-120934
Mattila, Jussi ; Soininen, Hilkka ; Koikkalainen, Juha ; Rueckert, Daniel ; Wolz, Robin ; Waldemar, Gunhild ; Lötjönen, Jyrki. / Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. In: Journal of Alzheimer's Disease. 2012 ; Vol. 32, No. 4. pp. 969-979.
@article{ccd7354ceddc44fb86b371a3a88a0312,
title = "Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects",
abstract = "In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60–80{\%}. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5{\%}, 95{\%} confidence interval: 48.6–54.2{\%}) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7{\%}, possibly enough to support earlier diagnostic decisions.",
keywords = "Clinical decision support, early Alzheimer's disease, mild cognitive impairment, patient selection",
author = "Jussi Mattila and Hilkka Soininen and Juha Koikkalainen and Daniel Rueckert and Robin Wolz and Gunhild Waldemar and Jyrki L{\"o}tj{\"o}nen",
note = "Project code: 77772",
year = "2012",
doi = "10.3233/JAD-2012-120934",
language = "English",
volume = "32",
pages = "969--979",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

Mattila, J, Soininen, H, Koikkalainen, J, Rueckert, D, Wolz, R, Waldemar, G & Lötjönen, J 2012, 'Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects', Journal of Alzheimer's Disease, vol. 32, no. 4, pp. 969-979. https://doi.org/10.3233/JAD-2012-120934

Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. / Mattila, Jussi (Corresponding Author); Soininen, Hilkka; Koikkalainen, Juha; Rueckert, Daniel; Wolz, Robin; Waldemar, Gunhild; Lötjönen, Jyrki.

In: Journal of Alzheimer's Disease, Vol. 32, No. 4, 2012, p. 969-979.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects

AU - Mattila, Jussi

AU - Soininen, Hilkka

AU - Koikkalainen, Juha

AU - Rueckert, Daniel

AU - Wolz, Robin

AU - Waldemar, Gunhild

AU - Lötjönen, Jyrki

N1 - Project code: 77772

PY - 2012

Y1 - 2012

N2 - In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60–80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6–54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.

AB - In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60–80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6–54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.

KW - Clinical decision support

KW - early Alzheimer's disease

KW - mild cognitive impairment

KW - patient selection

U2 - 10.3233/JAD-2012-120934

DO - 10.3233/JAD-2012-120934

M3 - Article

VL - 32

SP - 969

EP - 979

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -